Log In
Print this Print this

SHP611 (formerly HGT1110)

Also known as: formerly HGT 1110, HGT-1110

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionRecombinant human arylsulfatase A
Molecular Target
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase I/II
Standard IndicationLeukodystrophy
Indication DetailsTreat metachromatic leukodystrophy
Regulatory Designation U.S. - Orphan Drug (Treat metachromatic leukodystrophy);
EU - Orphan Drug (Treat metachromatic leukodystrophy)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today